A

Anebulo Pharmaceuticals
D

ANEB

1.26000
USD
-0.15
(-10.64%)
مغلق
حجم التداول
373
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
51,766,761
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
الأخبار
المقالات

العنوان: Anebulo Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.